Mumbai: India’s pharmaceutical sector dipped notably on Wednesday after US President Donald Trump outlined a phased tariff plan on imported generic medicines, fuelling concerns over the long‑term outlook for drugmakers that rely heavily on US sales. Nifty Pharma Emerges Worst-Performing Sector The Nifty Pharma index fell nearly 2 per cent in early trade, making it.
